Tag Archives: Hydroxychloroquine

Did Pfizer Buy Up All Production Facilities For Ivermectin?

Did Pfizer Buy Up All Production Facilities For Ivermectin?

Did Pfizer just buy up all production facilities for ivermectin, to increase prices or to destroy it?

Find out what’s the new viral claim, and what the FACTS really are!

 

Claim : Pfizer Just Bought Up All Production Facilities For Ivermectin!

People are sharing a video of Laura-Lynn & Friends show that was posted on 31 August 2021, with this message :

Breaking: Pfizer just bought all of the production facilities for Ivermectin…

Here is a short clip of Laura-Lynn Tyler Thompson making that claim about 33 minutes into her Passport to Hell video.

And here is my transcript of what she said :

Ivermectin and hydroxychloroquine are sold over-the-counter in Mexico and Costa Rica. Different places in the world – India, Uganda, Africa – they’ve been taking hydroxychloroquine for years, millions of them, decades, and they don’t have a high incidence of COVID-19.

I just heard today, I don’t know if any of you – you guys are so fast – cause I heard it right before I went to air, that Bill Gates has, no no no… it’s Pfizer, Pfizer has purchased the ivermectin organisation or the plants or you know where they create it, or something like that.

I just heard Pfizer has invested in that, uh huh (listening to her earpiece). So that’ll will be interesting – whether they jack the prices up on everything, or destroy it.

 

Truth : Pfizer Did NOT Buy Any Ivermectin Production Facility!

The truth is Pfizer did NOT buy any production facility for ivermectin.

Laura-Lynn Tyler Thompson appears to have made up the story, and here are the reasons why…

Fact #1 : Pfizer Does Not Make Ivermectin At All

First, let me just state it very clearly – Pfizer does not make ivermectin at all.

You can verify this by simply checking the full Pfizer product list.

Pfizer is also NOT making a copy of ivermectin to treat COVID-19.

Read more : Is Pfizer Making Copy Of Ivermectin To Treat COVID-19?

Fact #2 : Pfizer Did Not Buy Any Ivermectin Production Facility

Pfizer is a public-listed company, and would have to disclose any purchase of companies or assets like a factory / production facility to their shareholders.

If you take but 5 seconds to check their public press releases, you can see that Pfizer did not purchase any ivermectin production facility.

For example, Pfizer announced on 23 August 2021 that they purchased Trillium Therapeutics Inc. Just in case you are wondering, Trillium makes cancer treatments, not ivermectin.

Fact #3 : Pfizer Does Not Need To Buy Ivermectin Production Facility

If Pfizer decides to make ivermectin, they don’t need to buy any production facility.

Pfizer has more than 35 manufacturing facilities across 6 continents – most, if not all, of which are capable of churning out ivermectin if they so wish it.

Fact #4 : Hundreds Of Companies Make Ivermectin

Hundreds of pharmaceutical companies and compounding pharmacies manufacture ivermectin globally. India alone has 105 different brands of ivermectin!

It is therefore IMPOSSIBLE for even a big pharmaceutical company like Pfizer to buy up even a fraction of companies making ivermectin.

For Laura’s benefit – there is no such thing as an ivermectin organisation.

Fact #5 : Anyone Can Make Ivermectin

Even if they somehow buy over every single company currently manufacturing ivermectin, they cannot stop new companies from making it!

Ivermectin is an easy and cheap drug to make, and is patent-free. So virtually any small company, even a compounding pharmacy, can make it!

Fact #6 : Hydroxychloroquine Does Not Work Against COVID-19

Despite Laura’s bold claim – hydroxychloroquine (HCQ) has been proven NOT to work against COVID-19.

  • Prophylaxis : HCQ showed little to no effect in preventing COVID-19 in 6 trials with more than 6,000 participants
  • Treatment : HCQ did not reduce mortality or duration of mechanical ventilation in 30 trials with more than 10,000 COVID-19 patients.

The results were so clear-cut that the WHO stopped the hydroxychloroquine arm of the Solidarity Trial in June 2020.

Fact #7 : Ivermectin Not Proven To Work Against COVID-19

Ivermectin has been shown to work against COVID-19 in lab (in vitro) studies, but does NOT improve clinical outcomes or prevent transmission.

That is why the WHO and the vast majority of health authorities around the world DO NOT advocate using ivermectin to prevent or treat COVID-19.

Read more : Latest Ivermectin COVID-19 Study : What Does It Really Say?

Please SHARE this fact check with your family and friends, so they won’t get fooled by Laura-Lynn Tyler Thompson!

 

Please Support My Work!

Support my work through a bank transfer /  PayPal / credit card!

Name : Adrian Wong
Bank Transfer : CIMB 7064555917 (Swift Code : CIBBMYKL)
Credit Card / Paypal : https://paypal.me/techarp

Dr. Adrian Wong has been writing about tech and science since 1997, even publishing a book with Prentice Hall called Breaking Through The BIOS Barrier (ISBN 978-0131455368) while in medical school.

He continues to devote countless hours every day writing about tech, medicine and science, in his pursuit of facts in a post-truth world.

 

Recommended Reading

Go Back To > Health | Fact Check | Tech ARP

 

Support Tech ARP!

Please support us by visiting our sponsors, participating in the Tech ARP Forums, or donating to our fund. Thank you!

India Drops Ivermectin, HCQ + Favipiravir As COVID-19 Drugs!

India just dropped not only ivermectin, but also HCQ (hydroxychloroquine) and favipiravir to treat COVID-19!

Find out why they did so, and what it means for COVID-19 treatment in India!

 

India Drops Ivermectin, HCQ + Favipiravir As COVID-19 Drugs!

India had earlier been criticised for continuing to recommend HCQ (hydroxychloroquine) as prophylaxis since at least May 2020, even though it failed to prevent two massive COVID-19 surges.

Then they recommended the use of ivermectin in mild or asymptomatic cases of COVID-19 that are in home quarantine, even though it has not been proven to work against COVID-19.

On 27 May 2021, the Directorate General of Health Services of the Indian Ministry of Health and Family Welfare released updated Comprehensive Guidelines for Management of COVID-19 patients.

That updated COVID-19 treatment guidelines removed not just ivermectin, hydroxychloroquine and favipiravir, but also other popular off-label treatments like azithromycin, doxycycline, zinc and plasma therapy.

By dropping hydroxycholoroquine, India was finally acknowledging that HCQ simply does not work against COVID-19 – a fact that the world had known since June 2020, when the WHO Solidarity Trial dropped it after determining that it was ineffective against COVID-19.

As we explained before, the verdict on ivermectin is still out, so it simply does not make sense to use it as a mainstream COVID-19 treatment, outside of clinical trials.

The same goes for favipiravir, which is also under investigation as a potential treatment for COVID-19, after lab tests and small pilot studies in humans showed some benefit in reducing symptoms and duration of illness. However, there is still not enough evidence to use it to treat COVID-19 outside of clinical trials.

 

Indian COVID-19 Treatment w/o Ivermectin, HCQ + Favipiravir

The Indian treatment guidelines for COVID-19 is now much simpler, after removing a whole bunch of off-label drugs.

For example, there is basically no treatment for asymptomatic COVID-19 patients, bringing it in line with the rest of the world.

Oxygen support for mild COVID-19 still seems excessive, but it is a heck of a lot better than the earlier guidelines!

Only two off-label drugs are now authorised for emergency use against COVID-19 – remdesivir and tocilizumab, with the following warnings :

Remdesivir

  • Emergency Use Authorisation based on limited scientific evidence globally.
  • Only to be used in select moderate / severe hospitalised COVID-19 patients on supplemental oxygen, within 10 days of onset of disease.
  • Exercise extreme caution as this is an experimental drug with potential to harm.

Tocilizumab

  • Only approved for use in severe and critically-ill COVID-19 patients, that meet these conditions :
    a) no signs of improvement in oxygen requirement after 24-48 hours on corticosteroids
    b) has significantly raised inflammatory markets (C-Creative Protein ≥ 75 mg/L)
  • Must only be used with patients who are free of any bacterial / fungal / tuberculous infection.

 

Recommended Reading

Go Back To > Travel | Business | Home

 

Support Tech ARP!

If you like our work, you can help support us by visiting our sponsors, participating in the Tech ARP Forums, or even donating to our fund. Any help you can render is greatly appreciated!